Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-09 Purchase | 2021-12-13 4:02 pm | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 10,000 | $2.0622 | $20,622 | 73,905 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 09:02 am | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 45,000 | $3.5 | $157,500 | 63,905 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 09:01 am | Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director | 21,428 | $3.5 | $74,998 | 27,380 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 09:01 am | Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy | 14,285 | $3.5 | $49,998 | 14,285 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 09:00 am | Acer Therapeutics Inc. | ACER | Schelling Chris CEO 10% Owner | 142,857 | $3.5 | $500,000 | 1,892,857 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-19 Option Award | 2022-06-22 4:06 pm | N/A 2032-06-19 | Acer Therapeutics Inc. | ACER | Hayden Tanya Chief Operating Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-19 Ownership | 2022-06-22 4:04 pm | N/A 2031-06-01 | Acer Therapeutics Inc. | ACER | Hayden Tanya Chief Operating Officer | 0 | $0 | 42,500 (Direct) | View |
| 2022-02-21 Option Award | 2022-02-23 4:39 pm | N/A 2032-02-21 | Acer Therapeutics Inc. | ACER | Quartel Adrian W Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-21 4:07 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Paul Bernard H Chief People Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Ownership | 2022-01-21 4:04 pm | N/A 2029-05-08 | Acer Therapeutics Inc. | ACER | Paul Bernard H Chief People Officer | 0 | $0 | 65,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:32 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Seibt Matthew Chief Commercial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:29 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Schelling Chris CEO 10% Owner | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:28 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | PALMIN HARRY S Chief Opp. and Financial Offr | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:25 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Klopp John Michael CTO | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:24 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:22 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:20 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:18 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:15 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:10 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | Amello Jason Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:50 pm | N/A 2031-02-03 | Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-02-01 Ownership | 2021-02-05 4:47 pm | N/A N/A | Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer | 0 | $0 | 76,645 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:23 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | Seibt Matthew Chief Commercial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:21 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | Schelling Chris CEO 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:19 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | PALMIN HARRY S Chief Opp. and Financial Offr | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:18 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | Klopp John Michael CTO | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:15 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:14 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:12 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:10 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:08 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | Amello Jason Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:25 pm | N/A N/A | Acer Therapeutics Inc. | ACER | Andrews William T. Chief Medical Officer | 3,142 | $3.28 | 5,858 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:18 pm | N/A 2030-01-02 | Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:15 pm | N/A 2030-01-02 | Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:13 pm | N/A 2030-01-02 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:09 pm | N/A 2030-01-02 | Acer Therapeutics Inc. | ACER | Amello Jason Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2019-09-18 Option Award | 2019-09-25 2:20 pm | N/A 2029-09-18 | Acer Therapeutics Inc. | ACER | Klopp John Michael CTO | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-09-18 Ownership | 2019-09-25 2:17 pm | N/A 2028-01-15 | Acer Therapeutics Inc. | ACER | Klopp John Michael CTO | 0 | $0 | 36,000 (Direct) | View |
| 2019-09-18 Option Award | 2019-09-23 7:40 pm | N/A 2029-09-18 | Acer Therapeutics Inc. | ACER | PALMIN HARRY S Chief Opp. and Financial Offr | 40,000 | $0 | 40,000 (Direct) | View |